Transcription of Assessment report
{{id}} {{{paragraph}}}
Official address Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands An agency of the European Union Address for visits and deliveries Refer to Send us a question Go to Telephone +31 (0)88 781 6000 European Medicines Agency, 2021. Reproduction is authorised provided the source is acknowledged. 25 March 2021 EMA/CHMP/206970/2021 Committee for Medicinal Products for Human Use (CHMP) Assessment report Ponvory International non-proprietary name: ponesimod Procedure No. EMEA/H/C/005163/0000 Note Assessment report as adopted by the CHMP with all information of a commercially confidential nature deleted.
AVB Atrioventricular Block BAFF B cell-Activating Factor BCRP Breast Cancer Resistance Protein BID Bis In Die: twice a day BP Blood Pressure B/R Benefit / Risk BW Body Weight cAMP Cyclin Adenosine Monophosphate CBC Complete Blood Count CDA Confirmed Disability Accumulation CFA Complete Freund’s Adjuvant CFU Colony-Forming Unit
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}